https://gentaur.com/products/25205669-anti-human-mspr-ron-cd136-h5b14-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205670-anti-human-folr1-fra-mirvetuximab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205671-anti-human-b7-h1-pd-l1-cd274-lodapolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205672-anti-human-b7-h1-pd-l1-cd274-lodapolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205673-anti-human-b7-h1-pd-l1-cd274-lodapolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205674-anti-human-muc16-oregovomab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205675-anti-human-alp-seagen-patent-anti-alpp-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205676-anti-human-alp-seagen-patent-anti-alpp-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205677-anti-human-alp-seagen-patent-anti-alpp-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205678-anti-human-kid3-macrogenics-patent-anti-kid3-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205679-anti-human-kid3-macrogenics-patent-anti-kid3-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205680-anti-human-kid3-macrogenics-patent-anti-kid3-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205681-anti-human-igf1r-cd221-lonigutamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205682-anti-human-igf1r-cd221-lonigutamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205683-anti-human-igf1r-cd221-lonigutamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205684-anti-human-meflin-tokai-u-patent-anti-meflin-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205685-anti-human-meflin-tokai-u-patent-anti-meflin-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205686-anti-human-meflin-tokai-u-patent-anti-meflin-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205687-anti-human-ang2-vegfa-vanucizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205688-anti-human-ang2-vegfa-vanucizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205689-anti-human-il-1a-bermekimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205690-anti-human-il-1a-bermekimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205691-anti-human-il-1a-bermekimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205692-anti-human-erbb1-egfr-her1-losatuxizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205693-anti-human-erbb1-egfr-her1-losatuxizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205694-anti-human-erbb1-egfr-her1-losatuxizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205695-anti-shiga-toxin-e-coli-pritoxaximab-biosimilar 2026-07-30T13:13:37.219Z weekly 0.9 https://gentaur.com/products/25205696-anti-shiga-toxin-e-coli-pritoxaximab-biosimilar 2026-07-30T13:13:37.219Z weekly 0.9 https://gentaur.com/products/25205697-anti-shiga-toxin-e-coli-pritoxaximab-biosimilar 2026-07-30T13:13:37.219Z weekly 0.9 https://gentaur.com/products/25205698-anti-human-nt5e-cd73-mupadolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205699-anti-human-nt5e-cd73-mupadolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205700-anti-human-nt5e-cd73-mupadolimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205701-anti-human-ige-talizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205702-anti-human-ige-talizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205703-anti-human-ige-talizumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205704-anti-human-cd3-cd20-epcoritamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205705-anti-human-cd3-cd20-epcoritamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205706-anti-human-gd2-dinutuximab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205707-anti-human-gd2-dinutuximab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205708-anti-human-gd2-dinutuximab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205709-anti-human-tspan26-cd37-lilotomab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205710-anti-human-tspan26-cd37-lilotomab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205711-anti-human-tspan26-cd37-lilotomab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205712-anti-human-hgf-sf-tak-701-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205713-anti-human-hgf-sf-tak-701-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205714-anti-human-hgf-sf-tak-701-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205715-anti-human-fc-gamma-r1-medarex-patent-anti-fc-gamma-r1-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205716-anti-human-fc-gamma-r1-medarex-patent-anti-fc-gamma-r1-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205717-anti-human-fc-gamma-r1-medarex-patent-anti-fc-gamma-r1-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205718-anti-human-erbb1-egfr-her1-laprituximab-emtansine-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205719-anti-hbsag-ost-577-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205720-anti-hbsag-ost-577-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205721-anti-hbsag-ost-577-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205722-anti-human-erg-jackson-foundation-patent-anti-erg-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205723-anti-human-erg-jackson-foundation-patent-anti-erg-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205724-anti-human-erg-jackson-foundation-patent-anti-erg-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205725-anti-human-fcrn-nipocalimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205726-anti-human-fcrn-nipocalimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205727-anti-human-fcrn-nipocalimab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205728-anti-human-cd19-loncastuximab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205729-anti-human-cd19-loncastuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205730-anti-human-cd19-loncastuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205731-anti-human-il-13-lebrikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205732-anti-human-il-13-lebrikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205733-anti-human-il-13-lebrikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205735-anti-human-cd93-dcby02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205736-anti-human-cd93-dcby02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205737-anti-human-cd93-dcby02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205738-anti-shiga-toxin-e-coli-setoxaximab-biosimilar 2026-07-30T13:13:37.219Z weekly 0.9 https://gentaur.com/products/25205739-anti-shiga-toxin-e-coli-setoxaximab-biosimilar 2026-07-30T13:13:37.274Z weekly 0.9 https://gentaur.com/products/25205740-anti-shiga-toxin-e-coli-setoxaximab-biosimilar 2026-07-30T13:13:37.219Z weekly 0.9 https://gentaur.com/products/25205741-anti-human-cd123-cd3-flotetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205742-anti-human-cd123-cd3-flotetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205743-anti-human-sez6-abbv-011-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205744-anti-human-sez6-abbv-011-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205745-anti-human-sez6-abbv-011-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205746-anti-human-nampt-alt-100-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205747-anti-human-nampt-alt-100-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205748-anti-human-nampt-alt-100-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205749-anti-human-gpc2-glypican-2-nih-patent-anti-glypican-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205750-anti-human-gpc2-glypican-2-nih-patent-anti-glypican-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205751-anti-human-gpc2-glypican-2-nih-patent-anti-glypican-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205752-anti-human-adam9-imgc936-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205753-anti-human-adam9-imgc936-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205754-anti-human-adam9-imgc936-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205755-anti-human-icos-cd278-medi-570-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205756-anti-human-icos-cd278-medi-570-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205757-anti-human-icos-cd278-medi-570-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205758-anti-human-hepcidin-hamp-ludwig-maximilians-u-anti-hepsin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205759-anti-human-hepcidin-hamp-ludwig-maximilians-u-anti-hepsin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205760-anti-human-hepcidin-hamp-ludwig-maximilians-u-anti-hepsin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205761-anti-human-il-13-m1295-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205762-anti-human-il-13-m1295-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205763-anti-human-il-13-m1295-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205764-anti-human-cd47-lemzoparlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205765-anti-human-cd47-lemzoparlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205766-anti-human-cd47-lemzoparlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205767-anti-human-ige-ligelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205768-anti-human-ige-ligelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205769-anti-human-ige-ligelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205770-anti-rsv-f-motavizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205771-anti-rsv-f-motavizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205772-anti-rsv-f-motavizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205773-anti-human-tpbg-naptumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205774-anti-human-tpbg-naptumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205775-anti-human-tpbg-naptumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205776-anti-human-il-1rl1-st2-il-33r-melrilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205777-anti-human-il-1rl1-st2-il-33r-melrilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205778-anti-human-il-1rl1-st2-il-33r-melrilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205779-anti-human-il-1b-cdp484-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205780-anti-human-il-1b-cdp484-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205781-anti-human-il-1b-cdp484-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205782-anti-human-il-12-briakinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205783-anti-human-il-12-briakinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205784-anti-human-il-12-briakinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205785-anti-human-ifng-amg-811-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205786-anti-human-ifng-amg-811-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205787-anti-human-ifng-amg-811-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205788-anti-human-tnfalpha-il-17-abt122-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205789-anti-human-il-6-ifnb2-medarex-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205790-anti-human-il-6-ifnb2-medarex-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205791-anti-human-il-6-ifnb2-medarex-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205792-anti-ifng-emapalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205793-anti-ifng-emapalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205794-anti-ifng-emapalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205795-anti-human-igf-2-dx-2647-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205796-anti-human-igf-2-dx-2647-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205797-anti-human-igf-2-dx-2647-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205798-anti-rsv-f-palivizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205799-anti-rsv-f-palivizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205800-anti-rsv-f-palivizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205801-anti-human-egfr-fc-gamma-riiia-afm24-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205802-anti-human-egfr-fc-gamma-riiia-afm24-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205803-anti-human-cldn18-2-zolbetuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205804-anti-human-hgfr-c-met-sait301-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205805-anti-human-hgfr-c-met-sait301-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205806-anti-human-hgfr-c-met-sait301-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205807-anti-human-il-13-dectrekumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205808-anti-human-il-13-dectrekumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205809-anti-human-il-13-dectrekumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205810-anti-human-b7-h3-cd276-mirzotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205811-anti-human-b7-h3-cd276-mirzotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205812-anti-human-b7-h3-cd276-mirzotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205813-anti-human-il-2ra-cd25-camidanlumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205814-anti-human-il-2ra-cd25-camidanlumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205815-anti-human-il-2ra-cd25-camidanlumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205816-anti-human-igf1r-cd221-figitumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205817-anti-human-igf1r-cd221-figitumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205818-anti-human-igf1r-cd221-figitumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205819-anti-human-amyloid-beta-merck-anti-amyloid-beta-19-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205820-anti-human-amyloid-beta-merck-anti-amyloid-beta-19-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205821-anti-human-amyloid-beta-merck-anti-amyloid-beta-19-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205822-anti-human-cd3-bcma-teclistamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205823-anti-human-cd3-bcma-teclistamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205824-anti-human-icam1-cd54-bersanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205825-anti-human-icam1-cd54-bersanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205826-anti-human-icam1-cd54-bersanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205827-anti-human-gpc3-glypican-3-codrituzumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205828-anti-human-gpc3-glypican-3-codrituzumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205829-anti-human-il-13-h2l6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205830-anti-human-il-13-h2l6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205831-anti-human-il-13-h2l6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205832-anti-human-pdcd1-pd-1-cd279-nofazinlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205833-anti-human-pdcd1-pd-1-cd279-nofazinlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205834-anti-human-pdcd1-pd-1-cd279-nofazinlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205835-anti-human-pcsk9-lodelcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205836-anti-human-pcsk9-lodelcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205837-anti-human-pcsk9-lodelcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205838-anti-human-il-6-ifnb2-medi-5117-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205839-anti-human-il-6-ifnb2-medi-5117-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205840-anti-human-il-6-ifnb2-medi-5117-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205841-anti-human-il-4ra-cd124-medi2045-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205842-anti-human-il-4ra-cd124-medi2045-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205843-anti-human-il-4ra-cd124-medi2045-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205844-anti-human-cd20-ocrelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205845-anti-human-cd20-ocrelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205846-anti-human-cd20-ocrelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205847-anti-human-cd20-ocaratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205848-anti-human-cd20-ocaratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205849-anti-human-cd20-ocaratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205850-anti-human-sortilin-sort1-latozinemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205851-anti-human-sortilin-sort1-latozinemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205852-anti-human-sortilin-sort1-latozinemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205853-anti-human-erbb1-egfr-her1-depatuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205854-anti-human-erbb1-egfr-her1-depatuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205855-anti-human-erbb1-egfr-her1-depatuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205856-anti-human-il-6-ifnb2-siltuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205857-anti-human-il-6-ifnb2-siltuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205858-anti-human-il-6-ifnb2-siltuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205859-anti-human-il-21-avizakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205860-anti-human-il-21-avizakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205861-anti-human-il-21-avizakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205862-anti-human-il-15-disc0280-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205863-anti-human-il-15-disc0280-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205864-anti-human-il-15-disc0280-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205865-anti-human-integrin-av-itgav-cd51-intetumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205866-anti-human-integrin-av-itgav-cd51-intetumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205867-anti-human-integrin-av-itgav-cd51-intetumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205868-anti-human-il-20-cheng-kung-u-patent-anti-il-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205869-anti-human-il-20-cheng-kung-u-patent-anti-il-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205870-anti-human-il-20-cheng-kung-u-patent-anti-il-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205871-anti-human-igf1r-cd221-ganitumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205872-anti-human-igf1r-cd221-ganitumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205873-anti-human-igf1r-cd221-ganitumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205874-anti-human-gd2-emd-273063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205875-anti-human-gd2-emd-273063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205876-anti-human-gd2-emd-273063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205877-anti-human-il-10-bt-063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205878-anti-human-il-10-bt-063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205879-anti-human-il-10-bt-063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205880-anti-human-baff-il-17a-tibulizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205881-anti-human-baff-il-17a-tibulizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205882-anti-human-il-6-ifnb2-cstri-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205883-anti-human-il-6-ifnb2-cstri-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205884-anti-human-il-6-ifnb2-cstri-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205885-anti-human-il-6-ifnb2-chugai-sk2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205886-anti-human-il-6-ifnb2-chugai-sk2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205887-anti-human-il-6-ifnb2-chugai-sk2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205888-anti-human-il-5-abgenix-anti-il-5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205889-anti-human-il-5-abgenix-anti-il-5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205890-anti-human-il-5-abgenix-anti-il-5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205891-anti-human-integrin-al-itgal-cd11a-efalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205892-anti-human-integrin-al-itgal-cd11a-efalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205893-anti-human-integrin-al-itgal-cd11a-efalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205894-anti-human-hgfr-c-met-korea-ribb-patent-anti-cmet-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205895-anti-human-hgfr-c-met-korea-ribb-patent-anti-cmet-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205896-anti-human-hgfr-c-met-korea-ribb-patent-anti-cmet-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205897-anti-human-il-13-abrezekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205898-anti-human-il-13-abrezekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205899-anti-human-il-13-abrezekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205900-anti-human-il-23-ly2525623-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205901-anti-human-il-23-ly2525623-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205902-anti-human-il-23-ly2525623-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205903-anti-human-il-6ra-cd126-levilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205904-anti-human-il-6ra-cd126-levilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205905-anti-human-il-6ra-cd126-levilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205906-anti-human-hepcidin-hamp-ly2787106-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205907-anti-human-hepcidin-hamp-ly2787106-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205908-anti-human-hepcidin-hamp-ly2787106-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205909-anti-human-hgfr-c-met-metheresis-patent-anti-met-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205910-anti-human-hgfr-c-met-metheresis-patent-anti-met-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205911-anti-human-hgfr-c-met-metheresis-patent-anti-met-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205912-anti-human-lag3-cd223-ieramilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205913-anti-human-lag3-cd223-ieramilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205914-anti-human-lag3-cd223-ieramilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205915-igg1-kappa-isotype-control-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205916-igg1-kappa-isotype-control-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205917-anti-human-f8-factor-viii-novo-nordisk-patent-anti-factor-viii-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205918-anti-human-f8-factor-viii-novo-nordisk-patent-anti-factor-viii-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205919-anti-human-f8-factor-viii-novo-nordisk-patent-anti-factor-viii-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205920-anti-human-il-7ra-cd127-pf-06342674-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205921-anti-human-il-7ra-cd127-pf-06342674-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205922-anti-human-il-7ra-cd127-pf-06342674-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205923-anti-human-oxldl-okayama-u-patent-anti-oxldl-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205924-anti-human-oxldl-okayama-u-patent-anti-oxldl-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205925-anti-human-oxldl-okayama-u-patent-anti-oxldl-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205926-anti-human-il-6-ifnb2-merck-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205927-anti-human-il-6-ifnb2-merck-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205928-anti-human-il-6-ifnb2-merck-patent-anti-il-6-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205929-anti-human-amyloid-beta-kumamoto-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205930-anti-human-amyloid-beta-kumamoto-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205931-anti-human-amyloid-beta-kumamoto-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205932-anti-human-integrin-a5b1-bms-patent-anti-integrin-5-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205933-anti-human-integrin-a5b1-bms-patent-anti-integrin-5-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205934-anti-human-integrin-a5b1-bms-patent-anti-integrin-5-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205935-anti-human-il-13-cendakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205936-anti-human-il-13-cendakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205937-anti-human-il-13-cendakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205938-anti-human-il-33-itepekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205939-anti-human-il-33-itepekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205940-anti-human-il-33-itepekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205941-anti-human-il-6-ifnb2-sirukumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205942-anti-human-il-6-ifnb2-sirukumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205943-anti-human-il-6-ifnb2-sirukumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205944-anti-human-mesothelin-nih-patent-anti-mesothelin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205945-anti-human-mesothelin-nih-patent-anti-mesothelin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205946-anti-human-mesothelin-nih-patent-anti-mesothelin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205947-anti-human-il-23-brazikumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205948-anti-human-il-23-brazikumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205949-anti-human-il-23-brazikumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205950-anti-human-vegfr2-kdr-cd309-olinvacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205951-anti-human-vegfr2-kdr-cd309-olinvacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205952-anti-human-vegfr2-kdr-cd309-olinvacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205953-anti-human-liv-1-slc39a6-ladiratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205954-anti-human-liv-1-slc39a6-ladiratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205955-anti-human-liv-1-slc39a6-ladiratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205956-anti-human-il-13-gsk-679586-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205957-anti-human-il-13-gsk-679586-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205958-anti-human-il-13-gsk-679586-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205959-anti-human-lag3-cd223-encelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205960-anti-human-lag3-cd223-encelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205961-anti-human-lag3-cd223-encelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205962-anti-human-il-6-ifnb2-olokizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205963-anti-human-il-6-ifnb2-olokizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205964-anti-human-il-6-ifnb2-olokizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205965-anti-human-epcam-trop1-cd326-oportuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205966-anti-human-epcam-trop1-cd326-oportuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205967-anti-human-epcam-trop1-cd326-oportuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205968-anti-human-il-18-abt-325-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205969-anti-human-il-18-abt-325-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205970-anti-human-il-18-abt-325-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205971-anti-human-axl-ufo-ory012-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205972-anti-human-axl-ufo-ory012-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205973-anti-human-axl-ufo-ory012-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205974-anti-human-pdcd1-pd-1-cd279-pimivalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205975-anti-human-pdcd1-pd-1-cd279-pimivalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205976-anti-human-pdcd1-pd-1-cd279-pimivalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205977-anti-human-il-6-ifnb2-ziltivekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205978-anti-human-il-6-ifnb2-ziltivekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205979-anti-human-il-6-ifnb2-ziltivekimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205980-anti-human-il-23a-risankizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205981-anti-human-il-23a-risankizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205982-anti-human-il-23a-risankizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205983-anti-human-erbb1-egfr-her1-nimotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205984-anti-human-erbb1-egfr-her1-nimotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205985-anti-human-erbb1-egfr-her1-nimotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205986-anti-human-pcsk9-ongericimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205987-anti-human-pcsk9-ongericimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205988-anti-human-pcsk9-ongericimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205989-anti-human-il-13-ima-026-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205990-anti-human-il-13-ima-026-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205991-anti-human-il-13-ima-026-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205992-anti-human-erbb1-egfr-her1-modotuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205993-anti-human-erbb1-egfr-her1-modotuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205994-anti-human-erbb1-egfr-her1-modotuximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205995-anti-human-pac1-zelminemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205996-anti-human-pac1-zelminemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205997-anti-human-pac1-zelminemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205998-anti-human-integrin-av-itgav-cd51-abituzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25205999-anti-human-integrin-av-itgav-cd51-abituzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206000-anti-human-integrin-av-itgav-cd51-abituzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206001-anti-human-ngf-bngf-fasinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206002-anti-human-ngf-bngf-fasinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206003-anti-human-ngf-bngf-fasinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206004-anti-human-erbb1-egfr-her1-regeneron-patent-anti-egfr-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206005-anti-human-erbb1-egfr-her1-regeneron-patent-anti-egfr-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206006-anti-human-erbb1-egfr-her1-regeneron-patent-anti-egfr-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206007-anti-human-ptprc-cd45-novartis-patent-anti-cd45-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206008-anti-human-ptprc-cd45-novartis-patent-anti-cd45-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206009-anti-human-ptprc-cd45-novartis-patent-anti-cd45-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206010-anti-human-ige-omalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206011-anti-human-ige-omalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206012-anti-human-ige-omalizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206013-anti-human-b7-h1-pd-l1-cd274-opucolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206014-anti-human-b7-h1-pd-l1-cd274-opucolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206015-anti-human-b7-h1-pd-l1-cd274-opucolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206016-anti-human-tnfrsf7-cd27-organon-patent-anti-cd27-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206017-anti-human-tnfrsf7-cd27-organon-patent-anti-cd27-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206018-anti-human-tnfrsf7-cd27-organon-patent-anti-cd27-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206019-anti-human-tigit-ociperlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206020-anti-human-tigit-ociperlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206021-anti-human-tigit-ociperlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206022-anti-human-pdcd1-pd-1-cd279-penpulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206023-anti-human-pdcd1-pd-1-cd279-penpulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206024-anti-human-pdcd1-pd-1-cd279-penpulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206025-anti-human-osteopontin-ask8007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206026-anti-human-osteopontin-ask8007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206027-anti-human-osteopontin-ask8007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206028-anti-human-il-6ra-cd126-apx007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206029-anti-human-il-6ra-cd126-apx007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206030-anti-human-il-6ra-cd126-apx007-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206031-anti-human-notch1-pfizer-patent-anti-notch1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206032-anti-human-notch1-pfizer-patent-anti-notch1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206033-anti-human-notch1-pfizer-patent-anti-notch1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206034-anti-human-igf1r-cd221-robatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206035-anti-human-igf1r-cd221-robatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206036-anti-human-igf1r-cd221-robatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206037-anti-human-mmp9-yeda-patent-anti-mmp-9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206038-anti-human-mmp9-yeda-patent-anti-mmp-9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206039-anti-human-mmp9-yeda-patent-anti-mmp-9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206040-anti-human-phosphatidylserine-bavituximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206041-anti-human-phosphatidylserine-bavituximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206042-anti-human-phosphatidylserine-bavituximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206043-anti-human-osmr-vixarelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206044-anti-human-osmr-vixarelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206045-anti-human-osmr-vixarelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206046-anti-human-lingo1-opicinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206047-anti-human-lingo1-opicinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206048-anti-human-lingo1-opicinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206049-anti-human-lag3-cd223-favezelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206050-anti-human-lag3-cd223-favezelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206051-anti-human-lag3-cd223-favezelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206052-anti-human-mesothelin-bms-986148-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206053-anti-human-mesothelin-bms-986148-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206054-anti-human-mesothelin-bms-986148-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206055-anti-human-b7-h3-cd276-omburtamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206056-anti-human-b7-h3-cd276-omburtamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206057-anti-human-b7-h3-cd276-omburtamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206058-anti-human-pdcd1-pd-1-cd279-budigalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206059-anti-human-pdcd1-pd-1-cd279-budigalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206060-anti-human-pdcd1-pd-1-cd279-budigalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206061-anti-human-integrin-avb3-etaracizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206062-anti-human-integrin-avb3-etaracizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206063-anti-human-integrin-avb3-etaracizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206064-anti-human-pdcd1-pd-1-cd279-prolgolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206065-anti-human-pdcd1-pd-1-cd279-prolgolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206066-anti-human-pdcd1-pd-1-cd279-prolgolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206067-anti-human-inhbb-activin-b-oxford-brookes-u-patent-anti-activin-beta-b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206068-anti-human-inhbb-activin-b-oxford-brookes-u-patent-anti-activin-beta-b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206069-anti-human-inhbb-activin-b-oxford-brookes-u-patent-anti-activin-beta-b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206070-anti-human-pcsk9-schering-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206071-anti-human-pcsk9-schering-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206072-anti-human-pcsk9-schering-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206073-anti-human-cd20-ofatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206074-anti-human-cd20-ofatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206075-anti-human-cd20-ofatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206076-anti-human-ngf-bngf-as2886401-00-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206077-anti-human-ngf-bngf-as2886401-00-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206078-anti-human-ngf-bngf-as2886401-00-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206079-anti-human-complement-c5-pozelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206080-anti-human-complement-c5-pozelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206081-anti-human-complement-c5-pozelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206082-anti-human-lag3-cd223-miptenalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206083-anti-human-lag3-cd223-miptenalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206084-anti-human-lag3-cd223-miptenalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206085-anti-human-nt5e-cd73-uliledlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206086-anti-human-nt5e-cd73-uliledlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206087-anti-human-nt5e-cd73-uliledlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206088-anti-human-cd3-otelixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206089-anti-human-cd3-otelixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206090-anti-human-cd3-otelixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206091-anti-human-il-23-mirikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206092-anti-human-il-23-mirikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206093-anti-human-il-23-mirikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206094-anti-human-pdcd1-pd-1-cd279-ezabenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206095-anti-human-pdcd1-pd-1-cd279-ezabenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206096-anti-human-pdcd1-pd-1-cd279-ezabenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206097-anti-human-ctla-4-cd152-quavonlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206098-anti-human-ctla-4-cd152-quavonlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206099-anti-human-ctla-4-cd152-quavonlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206100-anti-human-csf2-gm-csf-plonmarlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206101-anti-human-csf2-gm-csf-plonmarlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206102-anti-human-csf2-gm-csf-plonmarlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206103-anti-human-pdcd1-pd-1-cd279-cetrelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206104-anti-human-pdcd1-pd-1-cd279-cetrelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206105-anti-human-pdcd1-pd-1-cd279-cetrelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206106-anti-human-par2-amgen-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206107-anti-human-par2-amgen-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206108-anti-human-par2-amgen-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206109-anti-human-pdcd1-pd-1-cd279-balstilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206110-anti-human-pdcd1-pd-1-cd279-balstilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206111-anti-human-pdcd1-pd-1-cd279-balstilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206112-anti-human-siglec-2-cd22-pinatuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206113-anti-human-siglec-2-cd22-pinatuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206114-anti-human-siglec-2-cd22-pinatuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206115-anti-human-fcrn-orilanolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206116-anti-human-fcrn-orilanolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206117-anti-human-fcrn-orilanolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206118-anti-human-asic1-regeneron-patent-anti-asic1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206119-anti-human-asic1-regeneron-patent-anti-asic1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206120-anti-human-asic1-regeneron-patent-anti-asic1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206121-anti-human-pdcd1-pd-1-cd279-retifanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206122-anti-human-pdcd1-pd-1-cd279-retifanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206123-anti-human-pdcd1-pd-1-cd279-retifanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206124-anti-human-rhd-cd240d-lfb-anti-rhd-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206125-anti-human-rhd-cd240d-lfb-anti-rhd-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206126-anti-human-rhd-cd240d-lfb-anti-rhd-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206127-anti-human-tnfrsf4-ox40-cd134-telazorlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206128-anti-human-tnfrsf4-ox40-cd134-telazorlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206129-anti-human-tnfrsf4-ox40-cd134-telazorlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206130-anti-human-siglec-15-cd33l3-medimmune-patent-anti-siglec-15-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206131-anti-human-siglec-15-cd33l3-medimmune-patent-anti-siglec-15-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206132-anti-human-siglec-15-cd33l3-medimmune-patent-anti-siglec-15-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206133-anti-human-pcsk9-ralpancizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206134-anti-human-pcsk9-ralpancizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206135-anti-human-pcsk9-ralpancizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206136-anti-human-lag3-cd223-fianlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206137-anti-human-lag3-cd223-fianlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206138-anti-human-lag3-cd223-fianlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206139-anti-human-tnfrsf4-ox40-cd134-revdofilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206140-anti-human-tnfrsf4-ox40-cd134-revdofilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206141-anti-human-tnfrsf4-ox40-cd134-revdofilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206142-anti-human-amyloid-beta-rockefeller-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206143-anti-human-amyloid-beta-rockefeller-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206144-anti-human-amyloid-beta-rockefeller-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206145-anti-human-pcsk9-rg7652-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206146-anti-human-pcsk9-rg7652-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206147-anti-human-pcsk9-rg7652-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206148-anti-human-tgfb1-nis793-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206149-anti-human-tgfb1-nis793-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206150-anti-human-tgfb1-nis793-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206151-anti-human-tnfsf12-tweak-ro5458640-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206152-anti-human-tnfsf12-tweak-ro5458640-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206153-anti-human-tnfsf12-tweak-ro5458640-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206154-anti-human-tgm2-transglutaminase-2-zampilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206155-anti-human-tgm2-transglutaminase-2-zampilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206156-anti-human-tgm2-transglutaminase-2-zampilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206157-anti-human-siglec-2-cd22-epratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206158-anti-human-siglec-2-cd22-epratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206159-anti-human-siglec-2-cd22-epratuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206160-anti-human-ngf-bngf-medi-578-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206161-anti-human-ngf-bngf-medi-578-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206162-anti-human-ngf-bngf-medi-578-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206163-anti-human-par2-regeneron-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206164-anti-human-par2-regeneron-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206165-anti-human-par2-regeneron-patent-anti-par-2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206166-anti-human-tnfrsf10b-trailr2-cd262-benufutamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206167-anti-human-tnfrsf10b-trailr2-cd262-benufutamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206168-anti-human-tnfrsf10b-trailr2-cd262-benufutamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206169-anti-human-tnfrsf5-cd40-ravagalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206170-anti-human-tnfrsf5-cd40-ravagalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206171-anti-human-tnfrsf5-cd40-ravagalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206172-anti-human-siglec-2-cd22-nci-m972-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206173-anti-human-siglec-2-cd22-nci-m972-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206174-anti-human-siglec-2-cd22-nci-m972-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206175-anti-human-cd20-regeneron-patent-anti-cd20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206176-anti-human-cd20-regeneron-patent-anti-cd20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206177-anti-human-cd20-regeneron-patent-anti-cd20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206178-anti-human-tau-bepranemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206179-anti-human-tau-bepranemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206180-anti-human-tau-bepranemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206181-anti-human-pdgfrb-cd140b-imc-2c5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206182-anti-human-pdgfrb-cd140b-imc-2c5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206183-anti-human-pdgfrb-cd140b-imc-2c5-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206184-anti-human-bst2-cd317-sbi-biotech-patent-anti-bst2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206185-anti-human-bst2-cd317-sbi-biotech-patent-anti-bst2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206186-anti-human-bst2-cd317-sbi-biotech-patent-anti-bst2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206187-anti-human-mrc2-cd280-quark-patent-anti-endo-180-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206188-anti-human-mrc2-cd280-quark-patent-anti-endo-180-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206189-anti-human-mrc2-cd280-quark-patent-anti-endo-180-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206190-anti-human-csf2-gm-csf-otilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206191-anti-human-csf2-gm-csf-otilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206192-anti-human-csf2-gm-csf-otilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206193-anti-human-gdf15-mic1-ponsegromab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206194-anti-human-gdf15-mic1-ponsegromab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206195-anti-human-gdf15-mic1-ponsegromab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206196-anti-human-siglec-15-cd33l3-ab-25e9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206197-anti-human-siglec-15-cd33l3-ab-25e9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206198-anti-human-siglec-15-cd33l3-ab-25e9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206199-anti-human-pdcd1-pd-1-cd279-tislelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206200-anti-human-pdcd1-pd-1-cd279-tislelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206201-anti-human-pdcd1-pd-1-cd279-tislelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206202-anti-human-f11-factor-xi-osocimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206203-anti-human-f11-factor-xi-osocimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206204-anti-human-f11-factor-xi-osocimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206205-anti-human-rtn4-nogo-atinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206206-anti-human-rtn4-nogo-atinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206207-anti-human-rtn4-nogo-atinumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206208-anti-human-pcsk9-merck-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206209-anti-human-pcsk9-merck-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206210-anti-human-pcsk9-merck-patent-anti-pcsk9-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206211-anti-human-slamf7-cs1-azintuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206212-anti-human-slamf7-cs1-azintuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206213-anti-human-slamf7-cs1-azintuxizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206214-anti-human-muc18-mcam-cd146-imaprelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206215-anti-human-muc18-mcam-cd146-imaprelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206216-anti-human-muc18-mcam-cd146-imaprelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206217-anti-human-tcr-nktt320-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206218-anti-human-tcr-nktt320-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206219-anti-human-tcr-nktt320-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206220-anti-human-integrin-a2b3-tadocizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206221-anti-human-integrin-a2b3-tadocizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206222-anti-human-integrin-a2b3-tadocizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206223-anti-human-tbfbr2-ly3022859-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206224-anti-human-tbfbr2-ly3022859-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206225-anti-human-tbfbr2-ly3022859-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206226-anti-human-pdcd1-pd-1-cd279-zimberelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206227-anti-human-pdcd1-pd-1-cd279-zimberelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206228-anti-human-pdcd1-pd-1-cd279-zimberelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206229-anti-human-tf-factor-iii-tissue-factor-cd142-tnx-832-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206230-anti-human-tf-factor-iii-tissue-factor-cd142-tnx-832-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206231-anti-human-tf-factor-iii-tissue-factor-cd142-tnx-832-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206232-anti-human-il-6ra-cd126-sapelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206233-anti-human-il-6ra-cd126-sapelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206234-anti-human-il-6ra-cd126-sapelizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206235-anti-human-slc2a8-vb1-050-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206236-anti-human-slc2a8-vb1-050-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206237-anti-human-slc2a8-vb1-050-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206238-anti-human-tenascin-c-tenatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206239-anti-human-tenascin-c-tenatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206240-anti-human-tenascin-c-tenatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206241-anti-human-il-33-torudokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206242-anti-human-il-33-torudokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206243-anti-human-il-33-torudokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206244-anti-human-tcr-tol101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206245-anti-human-tcr-tol101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206246-anti-human-tcr-tol101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206247-anti-human-rtn4-nogo-ng-101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206248-anti-human-rtn4-nogo-ng-101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206249-anti-human-rtn4-nogo-ng-101-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206250-anti-human-tnfrsf10b-trailr2-cd262-lexatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206251-anti-human-tnfrsf10b-trailr2-cd262-lexatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206252-anti-human-tnfrsf10b-trailr2-cd262-lexatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206253-anti-human-rhd-cd240d-roledumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206254-anti-human-rhd-cd240d-roledumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206255-anti-human-rhd-cd240d-roledumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206256-anti-human-slamf7-cs1-pdl241-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206257-anti-human-slamf7-cs1-pdl241-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206258-anti-human-slamf7-cs1-pdl241-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206259-anti-human-tspan26-cd37-ags67e-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206260-anti-human-tspan26-cd37-ags67e-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206261-anti-human-tspan26-cd37-ags67e-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206262-anti-human-tnfrsf8-cd30-brentuximab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206263-anti-human-s100a4-lk-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206264-anti-human-s100a4-lk-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206265-anti-human-s100a4-lk-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206266-anti-human-siglec-3-cd33-imgn779-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206267-anti-human-siglec-3-cd33-imgn779-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206268-anti-human-siglec-3-cd33-imgn779-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206269-anti-human-micb-u-washington-patent-anti-micb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206270-anti-human-micb-u-washington-patent-anti-micb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206271-anti-human-micb-u-washington-patent-anti-micb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206272-anti-human-tf-factor-iii-tissue-factor-cd142-chugai-patent-anti-tf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206273-anti-human-tf-factor-iii-tissue-factor-cd142-chugai-patent-anti-tf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206274-anti-human-tf-factor-iii-tissue-factor-cd142-chugai-patent-anti-tf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206275-anti-human-sphingosine-1-phosphate-sonepcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206276-anti-human-sphingosine-1-phosphate-sonepcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206277-anti-human-sphingosine-1-phosphate-sonepcizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206278-anti-human-pdcd1-pd-1-cd279-sasanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206279-anti-human-pdcd1-pd-1-cd279-sasanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206280-anti-human-pdcd1-pd-1-cd279-sasanlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206281-anti-human-cyr61-ccn1-roche-patent-anti-ccn1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206282-anti-human-cyr61-ccn1-roche-patent-anti-ccn1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206283-anti-human-cyr61-ccn1-roche-patent-anti-ccn1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206284-anti-human-tigit-etigilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206285-anti-human-tigit-etigilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206286-anti-human-tigit-etigilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206287-anti-human-tnfsf13-april-cd256-sibeprenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206288-anti-human-tnfsf13-april-cd256-sibeprenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206289-anti-human-tnfsf13-april-cd256-sibeprenlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206290-anti-human-ramp3-medella-patent-anti-ramp-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206291-anti-human-ramp3-medella-patent-anti-ramp-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206292-anti-human-ramp3-medella-patent-anti-ramp-3-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206293-anti-human-napi2b-slc34a2-upifitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206294-anti-human-napi2b-slc34a2-upifitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206295-anti-human-napi2b-slc34a2-upifitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206296-anti-human-tfpi-marstacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206297-anti-human-tfpi-marstacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206298-anti-human-tfpi-marstacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206299-anti-human-tau-tilavonemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206300-anti-human-tau-tilavonemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206301-anti-human-tau-tilavonemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206302-anti-human-pdcd1-pd-1-cd279-sintilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206303-anti-human-pdcd1-pd-1-cd279-sintilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206304-anti-human-pdcd1-pd-1-cd279-sintilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206305-anti-human-tnfrsf5-cd40-lucatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206306-anti-human-tnfrsf5-cd40-lucatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206307-anti-human-tnfrsf5-cd40-lucatumumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206308-anti-human-siglec-2-cd22-nci-m971-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206309-anti-human-siglec-2-cd22-nci-m971-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206310-anti-human-siglec-2-cd22-nci-m971-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206311-anti-human-tnfsf2-tnfa-hmak195-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206312-anti-human-tnfsf2-tnfa-hmak195-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206313-anti-human-tnfsf2-tnfa-hmak195-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206314-anti-human-prlr-prolactin-receptor-bay-1158061-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206315-anti-human-prlr-prolactin-receptor-bay-1158061-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206316-anti-human-prlr-prolactin-receptor-bay-1158061-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206317-anti-human-trkb-ntrk2-rinat-patent-anti-trkb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206318-anti-human-trkb-ntrk2-rinat-patent-anti-trkb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206319-anti-human-trkb-ntrk2-rinat-patent-anti-trkb-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206320-anti-human-pdcd1-pd-1-cd279-serplulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206321-anti-human-pdcd1-pd-1-cd279-serplulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206322-anti-human-pdcd1-pd-1-cd279-serplulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206323-anti-human-csf2-gm-csf-theraclone-patent-anti-gm-csf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206324-anti-human-csf2-gm-csf-theraclone-patent-anti-gm-csf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206325-anti-human-csf2-gm-csf-theraclone-patent-anti-gm-csf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206326-anti-human-vegf-varisacumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206327-anti-human-vegf-varisacumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206328-anti-human-vegf-varisacumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206329-anti-human-complement-c5-vilobelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206330-anti-human-complement-c5-vilobelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206331-anti-human-complement-c5-vilobelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206332-anti-human-tnfsf2-tnfa-cdp571-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206333-anti-human-tnfsf2-tnfa-cdp571-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206334-anti-human-tnfsf2-tnfa-cdp571-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206335-anti-human-vegfr2-kdr-cd309-vulinacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206336-anti-human-vegfr2-kdr-cd309-vulinacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206337-anti-human-vegfr2-kdr-cd309-vulinacimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206338-anti-human-endoglin-cd105-carotuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206339-anti-human-tnfrsf4-ox40-cd134-bms-986178-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206340-anti-human-tnfrsf4-ox40-cd134-bms-986178-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206341-anti-human-tnfrsf4-ox40-cd134-bms-986178-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206342-anti-human-pdcd1-pd-1-cd279-ucb-patent-anti-pd-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206343-anti-human-pdcd1-pd-1-cd279-ucb-patent-anti-pd-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206344-anti-human-pdcd1-pd-1-cd279-ucb-patent-anti-pd-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206345-anti-human-tnfsf5-cd40l-cd154-ruplizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206346-anti-human-tnfsf5-cd40l-cd154-ruplizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206347-anti-human-tnfsf5-cd40l-cd154-ruplizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206348-anti-human-vegfr2-kdr-cd309-alacizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206349-anti-human-vegfr2-kdr-cd309-alacizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206350-anti-human-vegfr2-kdr-cd309-alacizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206351-anti-human-il-33-tozorakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206352-anti-human-il-33-tozorakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206353-anti-human-il-33-tozorakimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206354-anti-human-tnfrsf10b-trailr2-cd262-tilogotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206355-anti-human-tnfrsf10b-trailr2-cd262-tilogotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206356-anti-human-tnfrsf10b-trailr2-cd262-tilogotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206357-anti-human-tslp-schering-patent-anti-tslp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206358-anti-human-tslp-schering-patent-anti-tslp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206359-anti-human-tslp-schering-patent-anti-tslp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206360-anti-human-tnfsf1-tnfb-lt-alpha-pateclizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206361-anti-human-tnfsf1-tnfb-lt-alpha-pateclizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206362-anti-human-tnfsf1-tnfb-lt-alpha-pateclizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206363-anti-human-cldn6-ae3-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206364-anti-human-cldn6-ae3-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206365-anti-human-cldn6-ae3-20-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206366-anti-human-complement-c5-tesidolumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206367-anti-human-complement-c5-tesidolumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206368-anti-human-complement-c5-tesidolumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206369-anti-human-tnfsf13b-baff-cd257-tabalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206370-anti-human-tnfsf13b-baff-cd257-tabalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206371-anti-human-tnfsf13b-baff-cd257-tabalumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206372-anti-human-mesothelin-anetumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206373-anti-human-amyloid-beta-solanezumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206374-anti-human-amyloid-beta-solanezumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206375-anti-human-amyloid-beta-solanezumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206376-anti-human-integrin-a5b1-volociximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206377-anti-human-integrin-a5b1-volociximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206378-anti-human-integrin-a5b1-volociximab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206379-anti-human-vegfr3-flt4-ly3022856-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206380-anti-human-vegfr3-flt4-ly3022856-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206381-anti-human-vegfr3-flt4-ly3022856-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206382-anti-human-cdh17-cadherin-17-10c12-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206383-anti-human-cdh17-cadherin-17-10c12-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206384-anti-human-cdh17-cadherin-17-10c12-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206385-anti-human-ceacam5-cea-cd66e-labetuzumab-govitecan-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206386-anti-human-tnfrsf5-cd40-iscalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206387-anti-human-tnfrsf5-cd40-iscalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206388-anti-human-tnfrsf5-cd40-iscalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206389-anti-human-vegfr2-kdr-cd309-at001-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206390-anti-human-vegfr2-kdr-cd309-at001-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206391-anti-human-vegfr2-kdr-cd309-at001-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206392-anti-human-amyloid-beta-u-illinois-scfv59-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206393-anti-human-amyloid-beta-u-illinois-scfv59-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206394-anti-human-amyloid-beta-u-illinois-scfv59-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206395-anti-human-cldn6-ab1-11-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206396-anti-human-cldn6-ab1-11-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206397-anti-human-cldn6-ab1-11-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206398-anti-human-tslp-tezepelumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206399-anti-human-tslp-tezepelumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206400-anti-human-tslp-tezepelumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206401-anti-human-dcstamp-u-rochester-patent-anti-dc-stamp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206402-anti-human-dcstamp-u-rochester-patent-anti-dc-stamp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206403-anti-human-dcstamp-u-rochester-patent-anti-dc-stamp-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206404-anti-human-cd19-denintuzumab-mmaf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206405-anti-human-pdcd1-pd-1-cd279-toripalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206406-anti-human-pdcd1-pd-1-cd279-toripalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206407-anti-human-pdcd1-pd-1-cd279-toripalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206408-anti-human-ceacam5-cea-cd66e-tusamitamab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206409-anti-human-erbb2-her2-cd340-biomab-patent-anti-her2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206410-anti-human-erbb2-her2-cd340-biomab-patent-anti-her2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206411-anti-human-erbb2-her2-cd340-biomab-patent-anti-her2-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206412-anti-human-hgfr-c-met-telisotuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206413-anti-human-hgfr-c-met-telisotuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206414-anti-human-gd3-ecromeximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206415-anti-human-gad65-u-washington-patent-anti-gad65-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206416-anti-human-gad65-u-washington-patent-anti-gad65-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206417-anti-human-gad65-u-washington-patent-anti-gad65-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206418-anti-human-erbb1-egfr-her1-cetuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206422-anti-human-gd2-naxitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206423-anti-human-gd2-naxitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206424-anti-human-gd2-naxitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206425-anti-human-trop2-datopotamab-deruxtecan-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206426-anti-human-tpbg-wyeth-patent-anti-5t4-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206427-anti-human-tpbg-wyeth-patent-anti-5t4-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206428-anti-human-tpbg-wyeth-patent-anti-5t4-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206429-anti-human-liv-1-slc39a6-ladiratuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206430-anti-human-liv-1-slc39a6-ladiratuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206431-anti-human-axl-ufo-enapotamab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206432-anti-human-ifnar1-medarex-patent-anti-ifnar-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206433-anti-human-ifnar1-medarex-patent-anti-ifnar-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206434-anti-human-ifnar1-medarex-patent-anti-ifnar-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206435-anti-human-amyloid-beta-lecanemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206436-anti-human-amyloid-beta-lecanemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206437-anti-human-amyloid-beta-lecanemab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206438-anti-human-sirpa-cd172a-bi-765063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206439-anti-human-sirpa-cd172a-bi-765063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206440-anti-human-sirpa-cd172a-bi-765063-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206441-anti-human-ror1-zilovertamab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206442-anti-human-vcam1-cd106-hanwha-patent-anti-vcam-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206443-anti-human-vcam1-cd106-hanwha-patent-anti-vcam-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206444-anti-human-vcam1-cd106-hanwha-patent-anti-vcam-1-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206445-anti-human-erbb2-her2-cd340-disitamab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206446-anti-human-cd19-obexelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206447-anti-human-cd19-obexelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206448-anti-human-cd19-obexelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206449-anti-human-ror2-ozuriftamab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206450-anti-human-pd-1-pd-l1-reozalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206451-anti-human-pd-1-pd-l1-reozalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206452-anti-human-pd-1-pd-l1-reozalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206453-anti-human-cd20-cd3-odronextamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206454-anti-human-cd20-cd3-odronextamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206455-anti-human-cd20-cd3-odronextamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206456-anti-human-cd3-epcam-m701-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206457-anti-human-cd3-epcam-m701-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206458-anti-human-cd3-epcam-m701-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206459-anti-human-cd79b-fc-gamma-r2b-cd32b-mgd010-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206460-anti-human-cd79b-fc-gamma-r2b-cd32b-mgd010-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206461-anti-human-cd79b-fc-gamma-r2b-cd32b-mgd010-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206462-anti-human-cd19-cd3-blinatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206463-anti-human-cd19-cd3-blinatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206464-anti-human-cd19-cd3-blinatumomab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206465-anti-human-pd-1-vegf-ivonescimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206466-anti-human-pd-1-vegf-ivonescimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206467-anti-human-pd-1-vegf-ivonescimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206468-anti-human-ctla4-pd-1-volrustomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206469-anti-human-ctla4-pd-1-volrustomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206470-anti-human-ctla4-pd-1-volrustomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206471-anti-human-4-1bb-tpbg-5t4-apv-527-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206472-anti-human-4-1bb-tpbg-5t4-apv-527-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206473-anti-human-4-1bb-tpbg-5t4-apv-527-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206474-anti-human-cd20-cd47-amulirafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206475-anti-human-cd20-cd47-amulirafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206476-anti-human-cd20-cd47-amulirafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206477-anti-human-lag-3-pd-1-emb-02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206478-anti-human-lag-3-pd-1-emb-02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206479-anti-human-lag-3-pd-1-emb-02-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206480-anti-human-cd3-dll3-tarlatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206481-anti-human-cd3-dll3-tarlatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206482-anti-human-cd3-dll3-tarlatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206483-anti-human-pd-1-tim-3-lomvastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206484-anti-human-pd-1-tim-3-lomvastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206485-anti-human-pd-1-tim-3-lomvastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206486-anti-human-b7-h3-egfr-ibi-334-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206487-anti-human-b7-h3-egfr-ibi-334-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206488-anti-human-b7-h3-egfr-ibi-334-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206489-anti-human-cd28-psma-nezastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206490-anti-human-cd28-psma-nezastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206491-anti-human-cd28-psma-nezastomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206492-anti-human-pd-l1-vegf-pm8002-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206493-anti-human-pd-l1-vegf-pm8002-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206494-anti-human-pd-l1-vegf-pm8002-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206495-anti-human-4-1bb-fap-ro7122290-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206496-anti-human-4-1bb-fap-ro7122290-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206497-anti-human-4-1bb-fap-ro7122290-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206498-anti-human-cmet-davutamig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206499-anti-human-cmet-davutamig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206500-anti-human-cmet-davutamig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206501-anti-human-cd3e-dll3-serum-albumin-hpn328-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206502-anti-human-cd3e-dll3-serum-albumin-hpn328-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206503-anti-human-cd3e-dll3-serum-albumin-hpn328-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206504-anti-human-4-1bb-pd-l1-enristomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206505-anti-human-4-1bb-pd-l1-enristomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206506-anti-human-4-1bb-pd-l1-enristomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206507-anti-human-cmet-egfr-emb01-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206508-anti-human-cmet-egfr-emb01-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206509-anti-human-cmet-egfr-emb01-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206510-anti-human-cmet-egfr-amivantamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206511-anti-human-cmet-egfr-amivantamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206512-anti-human-cmet-egfr-amivantamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206513-anti-human-lag-3-pd-1-tebotelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206514-anti-human-lag-3-pd-1-tebotelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206515-anti-human-lag-3-pd-1-tebotelimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206516-anti-human-pd-1-ctla-4-cadonilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206517-anti-human-pd-1-ctla-4-cadonilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206518-anti-human-pd-1-ctla-4-cadonilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206519-anti-human-ctla4-pd-1-vudalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206520-anti-human-ctla4-pd-1-vudalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206521-anti-human-ctla4-pd-1-vudalimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206522-anti-human-egfr-her3-izalontamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206523-anti-human-egfr-her3-izalontamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206524-anti-human-egfr-her3-izalontamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206525-anti-human-4-1bb-pd-l1-acasunlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206526-anti-human-4-1bb-pd-l1-acasunlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206527-anti-human-4-1bb-pd-l1-acasunlimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206528-anti-human-ca125-cd3-ubamatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206529-anti-human-ca125-cd3-ubamatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206530-anti-human-ca125-cd3-ubamatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206531-anti-human-cd3e-mesothelin-serum-albumin-hpn536-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206532-anti-human-cd3e-mesothelin-serum-albumin-hpn536-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206533-anti-human-cd3e-mesothelin-serum-albumin-hpn536-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206534-anti-human-tnf-alpha-hsa-ozoralizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206535-anti-human-tnf-alpha-hsa-ozoralizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206536-anti-human-tnf-alpha-hsa-ozoralizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206537-anti-human-cd47-pd-1-hx009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206538-anti-human-cd47-pd-1-hx009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206539-anti-human-cd47-pd-1-hx009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206540-anti-human-bcma-cd3-alnuctamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206541-anti-human-bcma-cd3-alnuctamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206542-anti-human-bcma-cd3-alnuctamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206543-anti-human-erbb2-her2-cd340-anbenitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206544-anti-human-erbb2-her2-cd340-anbenitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206545-anti-human-erbb2-her2-cd340-anbenitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206546-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206547-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206548-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206549-anti-human-dll4-vegf-navicixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206550-anti-human-dll4-vegf-navicixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206551-anti-human-dll4-vegf-navicixizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206552-anti-human-cd3-tpbg-gen1044-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206553-anti-human-cd3-tpbg-gen1044-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206554-anti-human-cd3-tpbg-gen1044-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206555-anti-human-lag-3-pd-1-tobemstomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206556-anti-human-lag-3-pd-1-tobemstomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206557-anti-human-lag-3-pd-1-tobemstomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206558-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206559-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206560-anti-human-lilrb1-lilrb2-ngm707-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206561-anti-human-cd3-gd2-nivatrotamab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206562-anti-human-cd3-gd2-nivatrotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206563-anti-human-cd3-gd2-nivatrotamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206564-anti-human-pd-l1-vegf-sotiburafusp-alfa-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206565-anti-human-pd-l1-vegf-sotiburafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206566-anti-human-pd-l1-vegf-sotiburafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206567-anti-human-bcma-cd3-linvoseltamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206568-anti-human-bcma-cd3-linvoseltamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206569-anti-human-bcma-cd3-linvoseltamab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206570-anti-human-il1a-il1b-lutikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206571-anti-human-il1a-il1b-lutikizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206572-anti-human-il1a-il1b-lutikizumab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206573-anti-human-her3-igf-1r-istiratumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206574-anti-human-her3-igf-1r-istiratumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206575-anti-human-her3-igf-1r-istiratumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206576-anti-human-b7-h4-cd3-gen1047-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206577-anti-human-b7-h4-cd3-gen1047-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206578-anti-human-b7-h4-cd3-gen1047-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206579-anti-human-4-1bb-her2-neu-yh32367-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206580-anti-human-4-1bb-her2-neu-yh32367-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206581-anti-human-4-1bb-her2-neu-yh32367-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206582-anti-human-ctla4-pd-l1-erfonrilimab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206583-anti-human-ctla4-pd-l1-erfonrilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206584-anti-human-ctla4-pd-l1-erfonrilimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206585-anti-human-tnfalpha-il17-remtolumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206586-anti-human-tnfalpha-il17-remtolumab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206587-anti-human-tnfalpha-il17-remtolumab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206588-anti-human-her2-neu-her3-zenocutuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206589-anti-human-her2-neu-her3-zenocutuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206590-anti-human-her2-neu-her3-zenocutuzumab-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206591-anti-human-pd-l1-tgf-tqb2858-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206592-anti-human-pd-l1-tgf-tqb2858-biosimilar 2026-06-08T13:14:42.075Z weekly 0.9 https://gentaur.com/products/25206593-anti-human-pd-l1-tgf-tqb2858-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206594-anti-human-c5-serum-albumin-gefurulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206595-anti-human-c5-serum-albumin-gefurulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206596-anti-human-c5-serum-albumin-gefurulimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206597-anti-human-4-1bb-cd40-gen1042-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206598-anti-human-4-1bb-cd40-gen1042-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206599-anti-human-4-1bb-cd40-gen1042-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206600-anti-human-egfr-her3-duligotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206601-anti-human-egfr-her3-duligotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206602-anti-human-egfr-her3-duligotuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206603-anti-human-il-17-il-17f-serum-albumin-sonelokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206604-anti-human-il-17-il-17f-serum-albumin-sonelokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206605-anti-human-il-17-il-17f-serum-albumin-sonelokimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206606-anti-human-cd20-cd3e-mosunetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206607-anti-human-cd20-cd3e-mosunetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206608-anti-human-cd20-cd3e-mosunetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206609-anti-human-her2-neu-zanidatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206610-anti-human-her2-neu-zanidatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206611-anti-human-her2-neu-zanidatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206612-anti-human-bcma-cd3-emb-06-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206613-anti-human-bcma-cd3-emb-06-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206614-anti-human-bcma-cd3-emb-06-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206615-anti-human-cd20-cd3-glofitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206616-anti-human-cd20-cd3-glofitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206617-anti-human-cd20-cd3-glofitamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206618-anti-human-bcma-cd3-elranatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206619-anti-human-bcma-cd3-elranatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206620-anti-human-bcma-cd3-elranatamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206621-anti-human-bcma-cd3-tnb-383b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206622-anti-human-bcma-cd3-tnb-383b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206623-anti-human-bcma-cd3-tnb-383b-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206624-anti-human-pd-1-tigit-rilvegostomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206625-anti-human-pd-1-tigit-rilvegostomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206626-anti-human-pd-1-tigit-rilvegostomig-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206627-anti-human-il-18-il-1-mas825-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206628-anti-human-il-18-il-1-mas825-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206629-anti-human-il-18-il-1-mas825-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206630-anti-human-cd28-egfr-regn7075-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206631-anti-human-cd28-egfr-regn7075-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206632-anti-human-cd28-egfr-regn7075-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206633-anti-human-il-13-il-4-romilkimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206634-anti-human-il-13-il-4-romilkimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206635-anti-human-il-13-il-4-romilkimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206636-anti-human-cd37-gen3009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206637-anti-human-cd37-gen3009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206638-anti-human-cd37-gen3009-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206639-anti-human-b7-h1-pd-l1-cd274-socazolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206640-anti-human-b7-h1-pd-l1-cd274-socazolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206641-anti-human-b7-h1-pd-l1-cd274-socazolimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206642-anti-human-cd3-bcma-teclistamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206643-anti-human-baff-il-17a-tibulizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206645-anti-human-cldn18-2-zolbetuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206646-anti-human-gprc5d-cd3-talquetamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206647-anti-human-tnfalpha-il-17-abt122-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206648-anti-human-cd3-cd20-epcoritamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206649-anti-human-ang2-vegfa-vanucizumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206650-anti-human-egfr-fc-gamma-riiia-afm24-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206651-anti-human-cd123-cd3-flotetuzumab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206652-anti-human-cd137-her2-cinrebafusp-alfa-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206653-anti-human-ang2-vegfa-faricimab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206654-anti-human-cd3-fcrl5-cevostamab-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206655-anti-human-tnfsf7-cd27l-cd70-vorsetuzumab-mafodotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206656-anti-human-muc16-sofituzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206657-anti-human-erbb1-egfr-her1-laprituximab-emtansine-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206658-anti-human-slitrk6-sirtratumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206659-anti-human-cd79b-iladatuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206660-anti-human-il-3ra-cd123-talacotuzumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206661-anti-human-canag-cantuzumab-mertansine-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206662-anti-human-ceacam5-cea-cd66e-tusamitamab-ravtansine-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206663-anti-human-erbb3-her3-patritumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206664-anti-human-napi2b-slc34a2-lifastuzumab-vedotin-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206665-anti-human-erbb1-egfr-her1-depatuxizumab-mmaf-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206666-anti-human-mesothelin-anetumab-ravtansine-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206667-anti-human-folr1-fra-mirvetuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206668-anti-human-muc16-oregovomab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206669-anti-human-mu5ac-ensituximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206670-anti-human-siglec-2-cd22-inotuzumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206671-anti-human-ca9-caix-girentuximab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206672-anti-human-cd79b-polatuzumab-vedotin-piiq-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9 https://gentaur.com/products/25206673-anti-human-dll3-rovalpituzumab-mmae-biosimilar 2026-06-03T16:46:28.937Z weekly 0.9